PH vs. JNJ
PH (Parker-Hannifin Corporation) and JNJ (Johnson & Johnson) are both stocks. PH operates in Specialty Industrial Machinery (Industrials), while JNJ operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, PH returned 24.75%/yr vs 10.06%/yr for JNJ. At a 0.25 correlation, their price movements are largely independent.
Performance
PH vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PH achieves a 0.89% return, which is significantly lower than JNJ's 13.43% return. Over the past 10 years, PH has outperformed JNJ with an annualized return of 24.75%, while JNJ has yielded a comparatively lower 10.06% annualized return.
PH
- 1D
- 0.09%
- 1M
- 0.49%
- YTD
- 0.89%
- 6M
- 0.81%
- 1Y
- 32.71%
- 3Y*
- 36.81%
- 5Y*
- 25.26%
- 10Y*
- 24.75%
JNJ
- 1D
- -0.26%
- 1M
- 5.50%
- YTD
- 13.43%
- 6M
- 16.43%
- 1Y
- 53.49%
- 3Y*
- 16.56%
- 5Y*
- 10.04%
- 10Y*
- 10.06%
PH vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PH Parker-Hannifin Corporation | 0.89% | 39.54% | 39.58% | 60.81% | -6.91% | 18.30% | 34.78% | 40.75% | -24.00% | 44.91% |
JNJ Johnson & Johnson | 13.43% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between PH and JNJ is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 1985 | 0.25 |
The correlation between PH and JNJ shifts across timeframes, from 0.06 (3 years) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PH:
$113.04B
JNJ:
$567.68B
PH:
$27.11
JNJ:
$8.65
PH:
32.58
JNJ:
26.85
PH:
1.37
JNJ:
0.89
PH:
5.40
JNJ:
5.86
PH:
7.26
JNJ:
6.99
PH:
$20.99B
JNJ:
$96.36B
PH:
$7.81B
JNJ:
$66.60B
PH:
$5.31B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PH vs. JNJ — Risk / Return Rank
PH
JNJ
PH vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Parker-Hannifin Corporation (PH) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PH | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.86 | ||
| Sortino ratioReturn per unit of downside risk | -2.63 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.57 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | 1.70 | 4.91 | -3.21 |
| Martin ratioReturn relative to average drawdown | 5.17 | 14.52 | -9.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PH | JNJ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.34 | 3.19 | -1.86 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.89 | 0.60 | +0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.78 | 0.55 | +0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | 0.54 | -0.09 |
Drawdowns
PH vs. JNJ - Drawdown Comparison
The maximum PH drawdown since its inception was -66.92%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for PH and JNJ.
Loading charts...
Drawdown Indicators
| PH | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.92% | -50.67% | -16.25% |
Max Drawdown (1Y)Largest decline over 1 year | -19.34% | -10.96% | -8.38% |
Max Drawdown (3Y)Largest decline over 3 years | -26.79% | -15.95% | -10.84% |
Max Drawdown (5Y)Largest decline over 5 years | -28.64% | -18.41% | -10.23% |
Max Drawdown (10Y)Largest decline over 10 years | -54.68% | -27.37% | -27.31% |
Current DrawdownCurrent decline from peak | -13.48% | -6.06% | -7.42% |
Average DrawdownAverage peak-to-trough decline | -15.33% | -11.88% | -3.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.34% | 3.70% | +2.64% |
Volatility
PH vs. JNJ - Volatility Comparison
Parker-Hannifin Corporation (PH) and Johnson & Johnson (JNJ) have volatilities of 5.59% and 5.80%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PH | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.59% | 5.80% | -0.21% |
Volatility (6M)Calculated over the trailing 6-month period | 18.60% | 12.41% | +6.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.62% | 16.87% | +7.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.61% | 16.87% | +11.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.69% | 18.47% | +13.22% |
Dividends
PH vs. JNJ - Dividend Comparison
PH's dividend yield for the trailing twelve months is around 0.84%, less than JNJ's 2.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.26% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
PH Parker-Hannifin Corporation | 0.84% | 0.80% | 1.00% | 1.25% | 1.73% | 1.25% | 1.29% | 1.65% | 1.97% | 1.32% | 1.80% | 2.60% |
Financials
PH vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Parker-Hannifin Corporation and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PH vs. JNJ - Profitability Comparison
PH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Parker-Hannifin Corporation reported a gross profit of 2.02B and revenue of 5.49B. Therefore, the gross margin over that period was 36.8%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
PH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Parker-Hannifin Corporation reported an operating income of 1.13B and revenue of 5.49B, resulting in an operating margin of 20.7%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
PH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Parker-Hannifin Corporation reported a net income of 904.00M and revenue of 5.49B, resulting in a net margin of 16.5%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
PH and JNJ have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JNJ has higher volatility (5.80%) compared to PH (5.59%). In terms of maximum drawdown, PH dropped -66.92% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.19 vs 1.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PH and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer